Page 20 - Read Online

Page 14 of 17 Peng et al. Microbiome Res Rep 2024;3:5 https://dx.doi.org/10.20517/mrr.2023.47

in the adult female bladder. J Clin Microbiol 2014;52:871-6. DOI PubMed PMC
5. Wolfe AJ, Brubaker L. “Sterile urine” and the presence of bacteria. Eur Urol 2015;68:173-4. DOI PubMed PMC
6. Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus
2018;4:128-38. DOI PubMed
7. Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature
2020;579:567-74. DOI PubMed PMC
8. Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer 2021;21:1325. DOI PubMed PMC
9. Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer. Gut Microbes 2020;11:1220-30. DOI PubMed PMC
10. Al-Ansari MM, AlMalki RH, Dahabiyeh LA, Abdel Rahman AM. Metabolomics-microbiome crosstalk in the breast cancer
microenvironment. Metabolites 2021;11:758. DOI PubMed PMC
11. Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med
2019;25:377-88. DOI PubMed
12. Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell
2021;12:426-35. DOI PubMed PMC
13. Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, Starkey MR. The microbiome and host mucosal
interactions in urinary tract diseases. Mucosal Immunol 2021;14:779-92. DOI PubMed
14. Chipollini J, Wright JR, Nwanosike H, et al. Characterization of urinary microbiome in patients with bladder cancer: Results from a
single-institution, feasibility study. Urol Oncol 2020;38:615-21. DOI
15. Xu W, Yang L, Lee P, et al. Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma. Am J Clin Exp
Urol 2014;2:57-61. PubMed PMC
16. Bučević Popović V, Šitum M, Chow CT, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep
2018;8:12157. DOI PubMed PMC
17. Wu P, Zhang G, Zhao J, et al. Profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect
Microbiol 2018;8:167. DOI PubMed PMC
18. Pederzoli F, Ferrarese R, Amato V, et al. Sex-specific alterations in the urinary and tissue microbiome in therapy-naïve urothelial
bladder cancer patients. Eur Urol Oncol 2020;3:784-8. DOI PubMed
19. Mansour B, Monyók Á, Makra N, et al. Bladder cancer-related microbiota: examining differences in urine and tissue samples. Sci
Rep 2020;10:11042. DOI PubMed PMC
20. Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science
2021;371:eabc4552. DOI PubMed PMC
21. Liu F, Liu A, Lu X, et al. Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Med 2019;8:6904-14.
DOI PubMed PMC
22. Parra-Grande M, Oré-Arce M, Martínez-Priego L, et al. Profiling the bladder microbiota in patients with bladder cancer. Front
Microbiol 2021;12:718776. DOI PubMed PMC
23. Ainsworth C. Microbiome: A bag of surprises. Nature 2017;551:S40-1. DOI PubMed
24. Johnson JS, Spakowicz DJ, Hong BY, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome
analysis. Nat Commun 2019;10:5029. DOI PubMed PMC
25. Bayne CE, Farah D, Herbst KW, Hsieh MH. Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis.
World J Urol 2018;36:1181-90. DOI PubMed
26. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13:800-12. DOI PubMed PMC
27. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014;157:121-41. DOI PubMed PMC
28. Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and
metastasis. Nat Commun 2020;11:5120. DOI PubMed PMC
29. Huang J, Zhang L, Wan D, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther
2021;6:153. DOI PubMed PMC
30. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J
Urol 1990;143:139-42. DOI
31. Alfano M, Canducci F, Nebuloni M, Clementi M, Montorsi F, Salonia A. The interplay of extracellular matrix and microbiome in
urothelial bladder cancer. Nat Rev Urol 2016;13:77-90. DOI PubMed PMC
32. Schwartz DJ, Chen SL, Hultgren SJ, Seed PC. Population dynamics and niche distribution of uropathogenic Escherichia coli during
acute and chronic urinary tract infection. Infect Immun 2011;79:4250-9. DOI PubMed PMC
33. Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 2015;12:584-96. DOI PubMed
34. Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA 2020;324:1980-91. DOI PubMed
35. LaRue H, Ayari C, Bergeron A, Fradet Y. Toll-like receptors in urothelial cells - targets for cancer immunotherapy. Nat Rev Urol
2013;10:537-45. DOI PubMed
36. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells
and microorganisms. Nat Rev Cancer 2013;13:759-71. DOI PubMed
37. Cao D, Qi Z, Pang Y, et al. Retinoic acid-related orphan receptor c regulates proliferation, glycolysis, and chemoresistance via the
PD-L1/ITGB6/STAT3 signaling axis in bladder cancer. Cancer Res 2019;79:2604-18. DOI PubMed